An interventional study of Yoga in Fibromyalgia, sponsored by University of Coimbra. Not yet recruiting at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-17.
Sponsored by University of Coimbra · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Fibromyalgia with a site in Portugal — 2 open to participants now, 2 under way, none of them phase 3. Fibromyalgia · Portugal.
Among the 14 studies in Fibromyalgia with a site in Portugal, this one is the 10th largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2024, is one of 7 with no phase, and was the 10th registered.
1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.
Browse Fibromyalgia studies →2 of the 14 studies in Fibromyalgia with a site in Portugal are open now. Recruiting first, the newest first:
University of Minho · Sites in Portugal
Ages 18+
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 60 across 938 interventional studies indexed under Fibromyalgia.
Median enrollment 60 across the 13 interventional studies, 93 across the 1 observational. Of the 11 that completed or were terminated, 4 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 14 have an industry lead sponsor. The 9 most frequent:
University of Coimbra is the lead sponsor of 89 studies on the registry; 27 are open to participants now.
University of Coimbra has 2 studies filed under Fibromyalgia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 14 studies in Fibromyalgia with a site in Portugal, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effectiveness of a complementary therapy using Yoga within the scope of First Health Care in Portugal, in pain control, quality of life and well-being of the patients with Fibromyalgia. It also, pretends to assess the viability and to identify the barriers to this sort of therapy in the context of Primary Health Care.
Fibromyalgia is a chronic and debilitating pain syndrome characterized by widespread and persistent pain, also affecting sleep quality and cognitive function. It is estimated to affect 3.6% of the population; however, since it is a condition that is often underdiagnosed, the actual numbers may be higher. It is also an incurable disease, so treatment is based on symptom management through pharmacological therapy, which is not always effective. Due to the inadequacy of pharmacological therapy, there is a need for complementary therapies, and despite the limited number of studies conducted in this area, some therapies based on meditative movement (notably yoga) are beginning to emerge, with beneficial effects reported on pain management and quality of life in these patients. Therefore, this study aims to investigate the benefits and feasibility of this type of intervention at the Primary Health Care level.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group used as comparison.
Yoga practioner group with a certified teacher, 3 times a week during 3 months.
Other: Yoga
Yoga with certified teacher, 3 times a week during 3 months.
Quality of Life
EQ-5D
Time frame: at the beggining and up to 3 months
Pain
Visual scale from 0 to 10 to measure pain
Time frame: at the beggining and up to 3 months
Global perception of change
Patient Global Impression of Change scale (portuguese validated version) 1 to 7 (1 is the worst, 7 is the best)
Time frame: up to 3 months
Well-being
EADS-21
Time frame: at the beggining and up to 3 months
Benefits perceived
Open question answered by the patients trough a written text
Time frame: up to 3 months
Difficulties perceived
Open question answered by the patients trough a written text
Time frame: up to 3 months
Replicability and ease of introducing treatment in the context of the Portuguese national health service
Open questions and SWOT analysis
Time frame: up to 3 months
Plan to share: No
Start is estimated for Dec 2024; primary completion for Feb 2025, 2 months later.
Of 439 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 2 months is below that.
Counting every sponsor, half of 452 studies reached it within 15 months; a quarter within 6 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Coimbra